<DOC>
	<DOCNO>NCT02150330</DOCNO>
	<brief_summary>Diminished ovarian reserve ( DOR ) one challenge field artificial reproductive technology ( ART ) still effective resolution disorder . In patent DOR , pregnancy rate 2-4 % . Eventually , patient DOR turn adapt child instead . In recent study , dehydroepiandrosterone ( DHEAS ) supplement might play role reverse diminish ovarian reserve improve prognosis ART . Cumulus cell , form cumulus-oocyte complex ( COC ) oocyte , play important role folliculogenesis , oocyte maturation , oocyte meiosis ovulation . Growing evidence disclose crosstalk oocyte cumulus cell paracrine regulation . Aberration crosswalks oocytes cumulus cell would associate poor prognosis folliculogenesis pregnancy outcomes . In patient ovarian hyper-stimulation protocol , assessment cumulus cell might reliable indicator folliculogenesis , embryo development , pregnancy rate pregnancy outcomes . These gene ( indicator ) , Hyaluronan synthase（HAS2 ) , Versican ( VCAN ) , Thrombospondin 1 ( THBS1 ) , Runt-related transcription factor 2 ( RUNX2 ) , Chromobox homolog 3 ( CBX3 ) , Tripartite motif-containing 28 ( TRIM28 ) , B-cell lymphoma 2 ( BCL2 ) ，BCL2-associated X protein ( BAX ) . This study assess gene expression cumulus cell DHEAS supplement patient DOR ovarian hyper stimulation protocol .</brief_summary>
	<brief_title>Effects Dehydroepiandrosterone Supplementation Cumulus Cells Gene Expression Under Controlled Ovarian Hyper-stimulation Patients With Diminished Ovarian Reserve</brief_title>
	<detailed_description>This study design prospective case-control study assess gene expression cumulus cell DHEAS supplement . Patients diminish ovarian reserve ovarian hyper-stimulation protocol evaluate Kaoshiung Veteran General Hospital January 1 , 2013 October 31 , 2013 . Approval study obtain hospital ` ethic committee , informed consent obtain patient ( VGHKS13-CT11-17 )</detailed_description>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>DOR : antral follicle count ( AFC ) less 5 , AntiMullerian hormone ( AMH ) less 1.0 ng/ml , previous total retrieve oocyte less 5 . Normal Control : antral follicle count ( AFC ) equal 5 , AntiMullerian hormone ( AMH ) equal 1.0 ng/ml , previous total retrieve oocyte equal 5 . Patient provide sign informed consent . Patient allergic history contraindication DHEAS usage .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Dehydroepiandrosterone</keyword>
	<keyword>DHEAS</keyword>
	<keyword>Gene expression cumulus cell .</keyword>
	<keyword>Folliculogenesis .</keyword>
	<keyword>Oocyte maturation .</keyword>
	<keyword>Ovarian hyper-stimulation protocol .</keyword>
	<keyword>Artificial reproduction technology .</keyword>
</DOC>